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Abstract: The transport of charge through the DNA base-pair stack offers a route to carry out redox
chemistry at a distance. Here we describe characteristics of this chemistry that have been elucidated and
how this chemistry may be utilized within the cell. The shallow distance dependence associated with these
redox reactions permits DNA-mediated signaling over long molecular distances in the genome and facilitates
the activation of redox-sensitive transcription factors globally in response to oxidative stress. The long-
range funneling of oxidative damage to sites of low oxidation potential in the genome also may provide a
means of protection within the cell. Furthermore, the sensitivity of DNA charge transport to perturbations
in base-pair stacking, as may arise with base lesions and mismatches, may be used as a route to scan the
genome for damage as a first step in DNA repair. Thus, the ability of double-helical DNA in mediating
redox chemistry at a distance provides a natural mechanism for redox sensing and signaling in the genome.
1. Introduction
Over the past several years, our laboratory has focused on
chemical studies of DNA. In particular, we have examined how
DNA facilitates electron-transfer reactions between donors and
acceptors that are bound to the double helix.1-4 We have found
that well-stacked DNA does indeed mediate redox reactions
between electron donors and acceptors well-separated from one
another on the DNA duplex and that DNA-bound oxidants can
even promote oxidative damage to DNA at sites far from the
binding site of the oxidant. Interestingly, these reactions can
occur only when the DNA base pairs are well stacked in the
duplex. Thus, DNA can facilitate redox reactions at a distance.
The DNA duplex, perhaps uniquely, can serve to mediate long-
range signaling.5
These studies prompted us to ask whether such chemistry
might occur within the cell. Organisms, from bacteria to humans,
face a variety of stresses to which they must respond in order
to survive. Reactive oxygen species (ROS) represent the
chemical threat that constitutes oxidative stress, and various
redox-active proteins and small molecules must be activated
by the cell to neutralize this threat (Figure 1).
But how is oxidative stress signaled within the genome to
activate a response? Moreover, how is the genome protected
from ROS? In Escherichia coli, glutathione, the redox buffer
of the cell, and thioredoxin-related proteins are regulated by
ROS-activated transcription factors. OxyR, for example, is
transcriptionally activated by H2O2 via oxidation of two cysteine
residues to a disulfide.6-8 SoxR is converted to the transcrip-
tionally active, oxidized form by superoxide-generating sensitiz-
ers, promoting soxS transcription. SoxS, in turn, promotes
superoxide dismutases, cluster repair proteins, and drug efflux
enzymes, among others.9 But must ROS be targeted to specific
sites within the genome to activate these transcription factors?
Are the proteins only activated when the concentrations of ROS
are sufficiently high that the proteins and ROS collide? And
what other damage to the cell must result under those conditions?
Mammalian redox sensing is still more complicated, with no
canonical redox sensor(s). Instead, various signal cascades are
activated, turning on DNA repair or inducing apoptosis, and
modulating the cellular response depending upon the source and
persistence of the cellular stress. Furthermore, in mammalian
cells, there is an inherent contradiction between redox sensing
and redox signaling. If ROS are used to mediate signaling
cascades, as is suspected for potentially dozens of receptor-
mediated pathways, this communication cannot be propagated
in a specific manner by modulating the global redox state of
the cell.8 Chemical specificity in signal transduction, relying
on spikes in local concentration of ROS, such as H2O2, allows
mutually exclusive pathways to employ redox signaling. In
contrast, redox sensing pathways, sensitive to damage to DNA
and to the global disulfide/thiol ratio, are activated only when
the buffering capacity of catalases, dismutases, glutathione,
thioredoxin, and glutaredoxins is overwhelmed.8,10 Thus, any
medium that could allow chemical control over the translocation
and distribution of oxidative radicals and damage increases the
potential sophistication of the cellular machinery.
We have asked whether DNA-mediated charge transport
might play some role in the response of the cell to oxidative
stress. DNA-mediated charge transport chemistry surely could
be utilized to protect the genome from oxidative damage,
funneling oxidizing equivalents to regions of the genome that
can accommodate higher mutation rates. Indeed, because DNA
charge transport chemistry can occur over long molecular
distances, might DNA charge transport chemistry be used also
as a means to facilitate long-range signaling across the genome
to activate the cellular response?
Here we describe recent studies to examine these questions.
We intend this report not as an exhaustive review of the field
but instead as a means to survey some key characteristics of
DNA charge transport chemistry that have been elucidated and
offer our perspective on how this unique chemistry might be
harnessed advantageously within the cell. We hope to apply a
Published on Web 01/04/2010
10.1021/ja907669c  2010 American Chemical Society J. AM. CHEM. SOC. 2010, 132, 891–905 9 891
chemical perspective to examine an important biological
problem and explore how the cell finds a chemical solution.
2. Redox State of DNA
The critical property of DNA with regard to redox sensing
is its ability to mediate charge transport over exceptionally long
distances.11-13 In our laboratory, we have observed DNA-
mediated charge transport (CT) over as far as 100 base pairs,
corresponding to 34 nm;4 other laboratories have observed CT
over comparable distances,14-16 particularly when oxidation of
the DNA is irreversible. Charge migration through DNA occurs
through the π-stack of base pairs. The planar, aromatic, hydro-
phobic, heterocyclic base pairs are stacked upon each other like a
pile of coins, protected from solvent by the sugar-phos-
phate backbone.17 It has been well-established that efficient charge
transfer into and out of the π-stack requires direct electronic
coupling to the bases, either through stacking interactions18-20 or
covalent, electronically conjugated linkage.21-23
We and others have seen long-range CT between donors and
acceptors bound to DNA, electrochemical oxidation and reduc-
tion of DNA-bound redox probes on DNA-modified electrodes,
and the generation of oxidative damage to DNA from a
distance.3 Figure 2 illustrates some of the classes of DNA
assemblies through which long-range CT has been documented.
The first evidence for long-range DNA-mediated CT was
the efficient fluorescence quenching of tethered, intercalated
[Ru(phen′)2(dppz)]*/2+ (E ≈ -0.8 V vs NHE) by tethered,
intercalated [Rh(phi)2(phen′)]3+ (E ≈ 0 V vs NHE) at long
range.24,25 Here, the photoexcited Ru is not a strong enough
reductant to add an electron directly to DNA, but it reduces the
Figure 1. Illustrative schematic of the generation and detoxification of hydrogen peroxide, an archetypical ROS, and some of its roles in mammalian redox
signaling. In this diagram, we see production of hydrogen peroxide in the mitochondria (bottom left) accompanied by its efficient detoxification in both the
matrix and the cytosol (center left) and the consequences of excess H2O2 reacting with ferrous iron (bottom left, right). H2O2 is a possible intermediate in
the receptor-mediated pathways that rely on NOX activation. (Top) Inside the nucleus, many transcription factors require further reduction, such as by
APE-1 (right). The blue dashed lines represent the equilibration between the bulk concentration of H2O2 in the cell and the local concentrations generated
as part of signaling or pathological processes; that these processes are functionally distinct illustrates how difficult it is to deconvolute redox sensing and
signaling pathways in mammals versus in yeast or prokaryotes. Poorly understood processes are represented as black dashes; in particular, the intermediate
species in receptor-initiated ROS signaling are not well-characterized. Abbreviations: ecSOD, extracellular superoxide dismutase; NADPH, nicotinamide
adenine dinucleotide phosphate; MAP3K, mitogen-activated protein kinase kinase kinase; MAP2K, mitogen-activated protein kinase kinase; NOX, NADPH
oxidase; PTP, protein tyrosine phosphatase; Trx, thioredoxin; ASK-1, apoptosis signaling kinase; Tpx, thioredoxin peroxidase; Cat, catalase; JNK, c-jun
N-terminal kinase; Gpx, glutathione peroxidase; Grd, glutathione reductase; MAO, monoamine oxidase; MnSOD, manganese superoxide dismutase; Acn,
aconitase; APE-1, apurinic/apyrimidinic endonuclease. These redox pathways and their inter-relationships are discussed in detail in refs 8–10, 148, 220 and
221.
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Rh complex on the subnanosecond time scale. Inspired by
groups that had found efficient oxidation of guanine by high-
energy photooxidants,26-28 we demonstrated that a tethered,
intercalated, photoexcited [Rh(phi)2(bpy′)]*/3+ (E ≈ 2.0 V vs
NHE) could indeed oxidatively damage guanine far from the
metal binding site.11,29 It was clear that oxidative radicals could
migrate over long distances in DNA, allowing “chemistry at a
distance”.
When the electronic coupling between a charge donor and
acceptor is weak, charge transfer proceeds through superex-
change, mediated by the orbitals of the bridge.30 The electronic
coupling between the donor and acceptor, and consequently the
rate, decays exponentially with increasing bridge length.
However, the oxidation yield of guanine by Rh complexes,11
photolytically generated sugar radical,31 and anthraquinone16
was found to be only weakly dependent on bridge length for
longer bridges. In some cases, such as for oxidation of
deazaguanine by photoexcited ethidium,32,33 this distance
dependence represents the distribution of CT-active structures,
rather than the inherent decay of the electronic coupling. The
rate of guanine oxidation by photoexcited stilbene in bridged
DNA hairpins has a far steeper distance dependence, which
depends on the driving force in a manner consistent with theory
for non-adiabatic electron transfer.34-37
To explain DNA-mediated CT over longer distances, a
mechanism was postulated wherein injected charge migrates
through DNA by hopping from site to site when it is injected
at an energy near or higher than that of the bases.15,31,38-47 The
rate of hopping, which is also an important CT mechanism in
proteins,48-50 has a geometric dependence on distance, and this
process can proceed over far longer distances than superex-
change.51 In the case of stilbene-capped hairpins, the transition
between superexchange and hopping has been directly observed,
as the rate of hole arrival at the acceptor is longer than the rate
of injection for donor-acceptor separation above two A-T base
pairs.46 The nature of the photooxidant can have a profound
effect on hopping even after injection, due to coulomb attraction
between the donor and the hole.52,53 Presumably, positively
charged metallointercalators have an opposite effect, promoting
migration of an injected hole away from the donor.3
A challenge to the hopping mechanism is the rugged energetic
environment of DNA.3 It has been postulated that variations in
the energies of neighboring sites are overcome by thermal
activation when direct superexchange is inadequate.54 The nature
of the hopping intermediates appears to be mixtures of localized
and delocalized states,16,55,56 with polaron formation providing
a complementary mechanism of overcoming the energetic barrier
to hopping.16,57,58 Calculations predict facile polaron delocal-
ization along 4-5 adenines;59 there is experimental evidence
consistent with this delocalization length as well.60,61 Confor-
mational dynamics also play a critical role, with base motions
being required to access CT-active conformations.52,56,60,62-64
We next considered whether large driving forces were
necessary for CT to proceed through DNA over long distances.
By assembling morphologically well-characterized DNA films
on gold and graphite electrodes, we and others have been able
to study DNA-mediated CT far below the potentials of the
isolated nucleosides.3,4,65,66 Remarkably, DNA can mediate CT
over long distances at potentials that should be insufficient for
occupation of the bridge. Although the rate has not been
characterized, it has been shown that CT through the short
alkanethiol linker is rate-limiting.4,23,67
Oxidative damage tends to localize at guanine repeat sites.
Although there is substantial spread in the measured and
calculated redox potentials of the DNA bases,68-70 all studies
support the fact that guanosine is the most readily oxidized
nucleoside, followed by adenosine, with cytidine and thymidine
having the most negative potential. Furthermore, the oxidation
potential of guanosine is more negative in the environment of
DNA, due both to base pairing and to stacking interactions, and
is also modulated by the conformational sampling of the DNA
environment.71 Specifically, 5′-purines decrease the potential
of guanosine via interactions with the stacking N7 nitrogen, with
the lowest potential site being the 5′-guanine of 5′-GGG-3′.72,73
Hence, electron holes equilibrate onto the guanine doublets and
triplets on a time scale that is faster than the trapping of
irreversible guanine damage products, leading to oxidative
damage at the 5′-guanines.
Better understood than the mechanistic aspects of DNA CT
are the characteristics of the DNA bridge that affect it. DNA-
mediated CT is exquisitely sensitive to the integrity of the
π-stack. Damage or binding events that perturb the dynamic
stacking will attenuate CT (Figure 3). This damage includes
mismatches,74,75 oxidative lesions,76 bending by DNA-binding
proteins,77,78 and abasic sites. Although at equilibrium most
mismatches have a structure similar to that of well-matched
DNA, more unstacked configurations are dynamically sampled.
The extent of this destacking is mirrored by the extent that each
individual base mismatch attenuates CT.75,79 The stable, well-
stacked GG mismatch is poorly discriminated by CT,80 although
a similarly stable GT wobble base pair gives significant
attenuation. Similarly, proteins that induce destacking, such as
TATA-binding protein, attenuate CT.77,78,81 In a particularly
illustrative example, the methylase M.HhaI, which extrudes a
cytidine from the duplex and replaces it with glutamine, sharply
suppresses the current through DNA.78 Upon incubation with
M.HhaI Q237W, which substitutes the aromatic, well-stacking
base tryptophan for the intercalating glutamine, the current is
restored to nearly that found through the unperturbed DNA,
demonstrating that the stacking interactions determine the CT
competence. The restriction enzyme R.BamHI contains a
guanidinium on R155 which forms a hydrogen bond with
guanine in the cognate site. This protein inhibits CT through
its binding site without bending the DNA, presumably due to
modulation of the potential of the guanine.82
In addition to affecting CT through the DNA, some DNA-
binding proteins can also participate in reactions with the
oxidized DNA. One class consists of the proteins that are redox-
active themselves (Vide infra). DNA-binding proteins containing
iron-sulfur clusters that we have studied, including EndoIII,
Figure 2. Three types of assemblies employed for studying DNA-mediated
CT. (a) An electrode is used to inject an electron and reduce a redox probe
attached to the DNA. (b) DNA-mediated CT is observed as the quenching
mechanism of photoexcited [Ru(phen′)2(dppz)]*/2+ by [Rh(phi)2(phen′)]3+.
Both of these reactions occur at potentials insufficient to reduce or oxidize
the DNA. (c) A high-energy photoexcited [Rh(phi)2(phen′)]*/3+ is employed
that is competent to oxidize all the DNA bases. Permanent chemical
decomposition products are observed at 5′-GG-3′ steps. Hence, DNA can
participate as both a mediator and a reactant in CT.
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MutY, UDG, and SoxR, are readily oxidized at DNA films that
allow direct access to the iron-sulfur cluster, demonstrating
that an appropriate electron-transfer path exists from the DNA
to the bound proteins.83-86 Without DNA to mediate CT, protein
electrochemistry is more challenging.85,87
Proteins and peptides can also react with DNA, oxidized from
a distance, to form protein-DNA cross-links. The guanine
radical that is generated upon DNA photooxidation degrades
to 8-oxo-7,8-dihydroguanine (oxoG), among other products,
following nucleophilic attack by water at the C8 carbon.26,88
After it was demonstrated that the tripeptides KYK and KWK
are oxidized by DNA with the radical localized on the tyrosine
and tryptophan, respectively (Figure 4),89-91 several groups
explored reactions of DNA-binding peptides that lack a stable
radical acceptor but have nucleophilic groups that might attack
the guanine radical.92-94 Consistent with the oxidative decom-
position products of covalent guanosine-lysine conjugates,95
trilysine forms cross-links with oxidized DNA. Cytochrome c,
which is not natively a DNA-binding protein but has extensive
lysine content, also undergoes cross-linking with DNA, dem-
onstrating the generality of this decomposition. The rate of cross-
linking is slower than 104 s-1,94 comparable to that which has
been reported for degradation of guanine radical in the presence
of in situ-generated superoxide. In the absence of protein,
superoxide, or other diffusing reductants, guanine radical
survives for seconds.96 Importantly, further oxidation events can
lead to more extensive damage products, both from the initial
oxoG intermediate97-99 and from the later protein-DNA
adduct.100 Ultimately, this pathway of decomposition both
competes and cooperates with oxoG and other guanine decom-
position products. In fact, one can consider that the time scale
of guanine radical degradation through secondary reactions
serves as the in ViVo clock that competes with the diffusion of
charge through the genome.
Since strong coupling is required for facile CT into and out
of DNA, it is not surprising that the chemical nature of the
oxidants plays a strong role in determining oxidation of DNA.
Small molecules can readily access the bases through either
groove. Pulse radiolysis studies employing SeO4 and SO4 have
found that the mechanism of radical injection varied with the
oxidant: oxidants of different energy abstract different hydrogens
from the bases.70,101 Intercalated photooxidants typically oxidize
DNA directly by single electron abstraction, either coincidentally
with or followed by proton transfer to generate a neutral
Figure 3. DNA-mediated CT is sharply attenuated by the presence of a mismatch or other lesions that affect stacking. The accumulated current through the
DNA is far less when oxidative lesions are present, including the physiologically relevant 8-oxoguanosine base-paired with adenosine and 5-hydroxycytidine
base-paired with guanine.
Figure 4. DNA-mediated CT from a strongly oxidizing intercalated
ruthenium complex to an intercalated lysine-tyrosine-lysine tripeptide (KYK)
proceeds through a guanine radical intermediate. Oxidation of KYK leads
to DNA-tyrosine cross-linking, while KWK is oxidized but does not form
a covalent product with the DNA. This serves as a model system for the
oxidation of DNA-bound proteins by radical species in DNA.
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radical.2,26,102,103 The nature of the chemical pathway of
oxidation can have profound effects on the role that DNA-
mediated CT has in determining the damage products.104,105
More biologically relevant, superoxide and hydrogen peroxide
are powerful oxidants and are associated with devastating DNA
damage in the absence of cellular defenses.106-108 Despite this,
they do not facilely oxidize DNA on their own.9,109 Rather,
superoxide oxidatively induces the release of Fe2+ from exposed
iron-sulfur clusters, which in turn reductively cleaves hydrogen
peroxide to hydroxyl anion and hydroxyl radical.110 It is the
latter species that readily oxidizes all four nucleobases by radical
attack111 or hydrogen abstraction,112 as well as the backbone
sugars by hydrogen abstraction.113 The base oxidative products,
in turn, can degrade to many products, including oxoG,
imidazolone, spiroiminodihydantoin, and oxazolone, with gua-
nine neutral radical as an intermediate following condensation.88
This general mechanism for peroxide toxicity has profound
implications for the role of cellular defenses against ROS and
helps explain the effectiveness of the cellular machinery in
responding to superoxide, i.e., that this molecule is several steps
upstream of the initial damage event and requires involvement
of free metal ions.
Thus, it is clear that it is not appropriate to discuss oxidative
stress of DNA as monolithic; individual oxidants will vary both
in their ability to chemically oxidize the bases and in the
products that they generate.105,114,115 Different oxidants can
produce the same products by different pathways, depending
on the availability of nucleophilic and radical species, and some
intermediates are reactive to a broad spectrum of available
species. Despite this, any process that generates neutral or
cationic guanine radical will allow CT to equilibrate it over
hundreds of base pairs prior to decomposition or cross-linking
of this intermediate.11
It is important to note that these DNA radical quenching
mechanisms have mostly been studied in the absence of the
variety of proteins that are normally bound. The histones that
package DNA in chromosomes provide a competing target for
oxidation. Yet once holes are injected into the DNA, seemingly
protected by the nucleosome, efficient DNA CT can still occur.
There is, moreover, a growing compendium of redox-active
proteins that bind and process DNA (Vide infra). Many of these
DNA-bound proteins may be facilely reduced or oxidized
through DNA-mediated CT.4,83 In fact, in some bacteria, a
variety of stress conditions also lead to the expression of the
ferritin analogue DNA-binding protein from starved cells (Dps),
which protects DNA from oxidative damage116-118 by seques-
tration of oxidative equivalents and free Fe2+.119,120 Whether
oxidizing equivalents are similarly funneled into DNA-bound
Dps has not yet been determined.
3. Shuttling of Oxidative Damage
Since pathways also exist for chemically irreversible decom-
position of guanine neutral and cationic radicals, guanine
damage is an eventual signature of DNA oxidation. Guanine
damage can lead to mutations during transcription, depending
on both the oxidation product and the particular polymerase
involved.115 A slight mutation rate is an adaptive advantage for
a population, but all organisms have a strong incentive to limit
mutations to their genomes and the consequent risk of lethality
or cancer.
Mutation rates are variable within genomes, with some
regions particularly “hot” for even silent genomic change.121,122
Hot regions tend to be correlated with genes that are less vital
for cellular survival.123 One proposal is that the variability in
mutation rate might be due to chromosomal structures that allow
damage agents preferential access to certain regions.124,125
Another explanation involves DNA-mediated CT.
It has been proposed that long-range hole migration in DNA
might serve a protective role, by controlling the distribution of
mutation rates.126,127 Oxidative damage accumulates most
readily in polypurine regions, particularly at multiple G sites.
If holes accumulate at these sites, then they will be depleted
from other regions of DNA, and damage will occur selectively
in the polypurine regions. Interestingly, polypurine regions have
been shown to be statistically enriched in promoter regions
versus transcribed or intergenic sequences of DNA.128,129
Furthermore, oxidative damage to polypurine regions within
promoter regions might modulate transcription factor binding;
there is evidence for this in the binding sites for NF-kB, AP-1,
and HIF-1.130-134 Polypurine regions are also critical to
quadruplex formation in telomeres, though in this case it appears
that the specific conformation of the quadruplex determines
whether DNA CT funnels damage to the guanines inside the
structure.135,136
An obvious challenge to this mechanism is the presence of
DNA sequence motifs, such as ATAT, that do not mediate CT
well. In one notable experiment, GG radical decomposition was
measured with and without a nearby oxoG, which serves as a
low-potential radical trap.137 With some sequences, the presence
of the oxoG protected the GG from oxidative damage. With
intervening ATTA, however, the oxoG had no effect on GG
damage. Similarly, a TTTT bridge was found to prevent
transport between GG and oxoG.138 Of course, as discussed
above, the superoxide generated in these experiments is associ-
ated with an increase in the guanine radical decomposition rate
of about 2 orders of magnitude.96,103 [Rh(phi)2(bpy)]2+, the
reduced state generated from oxidation of guanine by photo-
excited [Rh(phi)2(bpy)]3+, cannot generate superoxide. In this
case, guanine radical equilibrates over 200 Å prior to chemical
decomposition.11 Furthermore, the equilibration of damage is
not affected by nucleosome formation when Rh is used as the
photooxidant.139 A contrary result was found for another
sequence in which nucleosome formation protects a single GG
in the binding domain from damage when anthraquinone is used
as the photooxidant, with evidence for DNA-protein cross-
link formation near the photooxidant.140,141 It was not estab-
lished whether superoxide generation plays a role in the damage
distribution, although presumably since the protected guanine
site is accessible to hydroxyl radical in the presence and absence
of the nucleosome, it is also accessible to superoxide in both
cases.
Two series of experiments have assayed for whether this
damage funneling occurs inside the organelles of living cells.
In the first, the distribution of oxidative DNA damage induced
by photoexcited [Rh(phi)2(bpy)]3+ was determined inside iso-
lated HeLa nuclei; in the second, HeLa mitochondrial DNA was
studied.12,142 The type of damage induced by [Rh(phi)2(bpy)]3+
is dictated by the excited state of the metal complex. Excitation
at 365 nm generates the interligand CT state which is a powerful
oxidant, with E(Rh*3+/2+) ) 2.0 V vs NHE, competent for direct
oxidation of guanine in DNA to produce guanine radical.29,143
At higher energy excitation (308 nm), a ligand-centered state
abstracts a sugar hydrogen to promote strand scission at the
binding site of the metal complex.144 By comparing the sites
of guanine damage induced by photoexcitation at these two
wavelengths, the binding profile of the metal complex can be
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directly compared to the oxidative damage profile. In the absence
of DNA-mediated CT, these two profiles should be identical.
For both isolated nuclei and isolated mitochondria, the
damage sites are distinct from the binding sites. Damage occurs
preferentially at the 5′-guanine of multiple guanine sites,
indicating CT as the damage mechanism. The presence of DNA-
bound protein affects neither the formation of the formami-
dopyridine damage product in nuclei12 nor the formation of
alkali-sensitive damage products in mitochondrial DNA.142 The
damage profiles in the hypervariable region of the mitochondrial
genome were identical both for photooxidation inside the
isolated mitochondria and for photooxidation on the mitochon-
drial DNA in isolation (Figure 5).142,145 Damage in a noncoding
region, termed the hypervariable region, localizes specifically
to three regions: one is a flexible sequence, while the other two
are long polypurine tracts of presumably lower potential. One
of these is in conserved sequence block II (CSBII), which is
the site of replication initiation for the mitochondrial genome.146
Mitochondria are subject to extensive oxidative damage, due
to the leakage of ROS from the respiratory pathway.147,148
Simultaneously, it is essential to protect the integrity of the
mitochondrial genome, as the mitochondria are important actors
in the apoptotic cascade; mutation of the mitochondrial genome
in the presence of oxidative damage directly affects the ability
of the cell to respond to an excess of genomic damage. Hence,
it is not surprising that mitochondrial replication is strictly
regulated. Presumably, damage to CSBII serves to inhibit
binding of a ribonuclease, MRP, which is required for subse-
quent replication, and hence this damage prevents the propaga-
tion of mitochondrial genomes that are under severe oxidative
stress. As further evidence for the importance of this site to
mitochondrial genomic maintenance, CSBII is a hot spot for
mutation in breast and neck cancer.149-151 Hot spots for
oxidatively induced mutation that are outside of CSBII also
correlate with the hot spots for mutation found in cancer.151,152
What are the consequences of DNA CT on the profile of
damage? First, oxidative damage will be preferentially localized
to specific regions of the genome. Second, although oxoG is a
major biomarker of oxidative stress, oxoG can also absorb
oxidative radicals in the DNA and undergo decomposition to
further products, and a substantial amount of oxidative damage
will instead lead to protein cross-links. Finally, redox-active
proteins can serve to protect DNA from oxidative damage by
absorbing the holes;153 we have directly observed this behavior
with both SoxR and MutY.13,154 In fact, oxidation of the DNA-
bound protein can not only repair the damage but also activate
a response.
4. DNA-Mediated Redox Signaling and Sensing
The general way that the cell responds to oxidative stress
involves the activation of transcription factors that are sensitive
to the overall redox state of the cell.155 Sensing of cellular redox
transformation by these DNA-bound proteins elicits a specific
response that is propagated to the transcriptional machinery,
which then alters expression of genes that repair or mitigate
oxidative damage. These ROS-sensitive transcriptional regula-
tors are present throughout the three domains of life, and their
diversity illustrates the breadth of oxidative reactions experi-
enced by different organisms. In general, prokaryotic and other
single-celled organisms experience acute exposure to ROS, and
the corresponding stress response is highly dynamic to maximize
individual cell survival.156 Multicellular eukaryotic organisms
experience more chronic oxidative stress. In these organisms,
regulatory responses are often decoupled from ROS sensing.
The regulatory consequences are focused on long-term, constitu-
tive protection and are intimately linked to regulation of cell
cycle progression, apoptosis, and senescence. In all organisms,
the chemical mechanisms governing activation of redox-
sensitive transcription factors are not well understood, even
though these processes lie at the crux of physiologically relevant
processes such as cancer and aging in eukaryotes and antibiotic
resistance and virulence in prokaryotes.
4.1. Activation of SoxR by DNA-Mediated CT. SoxR is a
well-characterized example of a bacterial redox-sensitive tran-
scriptional regulator.157 While most studied in enteric bacteria
(such as E. coli), SoxR homologues are widely represented
throughout bacteria though they are not conserved in higher
organisms.158 SoxR is an interesting target for study, since
general mechanisms of activation may be conserved in other
transcriptional regulators. Furthermore, SoxR in Pseudomonas
aeruginosa has been linked to the metabolism of phenazine
derivatives,158,159 small molecules implicated in virulence in
pathogenic strains of P. aeruginosa.160 Activation of E. coli
SoxR turns on the soxS response, which induces transcription
of ∼50 genes involved in antioxidant production and oxidative
damage repair as well as genes involved in multidrug resistance
and heavy metal detoxification.161 SoxR homologues beyond
the enterics do not trigger expression of soxS homologues but
instead induce expression of genes putatively involved in export
Figure 5. The conserved sequence block II (CSBII) serves as a checkpoint
for mitochondrial DNA replication. Reactive oxygen species (ROS)
introduce oxidative damage to the DNA, which we have shown to be
funneled to the long polypurine region in CSBII, leading to oxidative
decomposition of guanine to 8-oxoguanine at this site. This damage might
interrupt specific CSBII-RNase interactions that are required for replication.
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and transformation of redox-active small molecules.158,159 These
molecules are implicated in a variety of biological processes
within the cell, including modulation of the NAD+/NADH pool,
quorum sensing, and defense against competitor bacteria.
SoxR is related to the MerR-like family of transcriptional
sensors, all of which share a common scaffold.162 These
transcription factors adopt a homodimer configuration where
each monomer consists of a DNA-binding domain, a coiled-
coil dimerization domain, and a functionally unique sensor
domain. The sensor domain in SoxR contains a [2Fe2S] cluster,
and the sensing capacity of this domain resides in the redox
activity of its iron-sulfur cluster.163 Oxidation of the [2Fe2S]+
cluster in SoxR activates soxS transcription up to 100-fold.
SoxR binds to a symmetric sequence flanked by the -10 and
-35 elements of the soxS promoter.162 These elements are
separated by a 19 bp spacer which hinders RNA polymerase
recruitment in the absence of SoxR activation. Upon activation,
the SoxR-bound DNA undergoes significant distortion and
underwinding to bring the soxS promoter elements into the
optimal position. A recent 2.8 Å X-ray crystal structure of
oxidized SoxR in complex with a 20 bp fragment of the soxS
promoter sequence confirms these DNA conformational
changes.164
The mechanism of SoxR activation at the sensor domain is
not well understood, however. Diverse superoxide-generating
agents such as paraquat are known to induce E. coli SoxR
activation in Vitro and in ViVo.163,165 SoxR activation has also
been demonstrated upon exposure to macrophage-generated
nitric oxide, resulting in SoxR-bound dinitrosyl iron com-
plexes.166 In either case, activation is rapid, with maximal SoxR
oxidation and soxS induction occurring within minutes of
cellular exposure to redox cycling agents.165 It is not known,
however, if ROS react directly with the sensor moiety in SoxR
or if activation occurs by alternate mechanisms. The possibility
of the latter case is supported by the high reactivity of ROS
with many other cellular components, including DNA.9,111,167
Furthermore, in bacterial species outside the enterics, SoxR
activation may involve redox-active antibiotics.158,159 In these
bacteria, SoxR induction can occur in the absence of oxygen.
Interestingly, soxR genes from these disparate species can
complement each other,168 indicating that activation of SoxR
throughout bacteria may occur by common pathways or that
SoxR has inherent flexibility in its activation mechanism. In
sum, it is unlikely that direct superoxide reaction with the
sensing domain of SoxR is the primary option for activation of
these proteins.
In understanding the possible activation mechanisms of SoxR,
it is important to consider the redox potential of the [2Fe2S]
cluster. The potentials of E. coli and P. aeruginosa SoxR in
the absence of DNA have been determined by redox titration
as -290 mV vs NHE.163,169 This relatively low value, in light
of the overall cytosolic potential within these cells (largely
governed by the NADPH/NADP+ potential of -340 mV vs
NHE),170 indicates that free SoxR could be significantly oxidized
under ambient conditions. Independent experimental evidence,
however, predicts that SoxR is mostly reduced during normal
aerobic growth.
Within the cell, however, SoxR is likely bound to the soxS
promoter site most of the time, and interaction with DNA may
change the environment of the iron-sulfur cluster and its redox
potential. Indeed, measurements of SoxR bound to DNA-
modified electrodes reveal that the midpoint potentials of P.
aeruginosa and E. coli SoxR are both ∼+200 mV vs NHE.85
These higher values are reasonable given the reduced resting
state of SoxR in these organisms, and, significantly, they indicate
that only strong oxidants may induce DNA-bound SoxR
activation. The nearly 500 mV shift in the redox potential that
occurs upon DNA association also raises interesting questions
about the origins of this phenomenon. SoxR does not display
differential binding affinity for the soxS promoter site in the
oxidized and reduced forms.171 While a comparison of the X-ray
crystal structures of oxidized SoxR with and without DNA
indicates no significant structural changes in SoxR in the
presence of DNA, these structures show dramatic changes in
the DNA structure in the activated SoxR:DNA complex.166
Thus, the potential shift may provide the driving force for
conformational changes induced in the protein or DNA upon
SoxR oxidation (Figure 6).
DNA-bound SoxR has a high redox potential, a low copy
number (and thus likely remains bound to its promoter site the
majority of the time within the cell), and a fast response time
upon exposure to environmental oxidants. In this context, it is
interesting to consider the possibility that SoxR may be activated
through the DNA via DNA-mediated CT chemistry. This
possibility has already been examined in DNA-mediated
electrochemical and photooxidation experiments.13,85 SoxR is
readily accessible to oxidation and reduction via the DNA base-
pair stack. Importantly, harnessing this chemistry may allow
SoxR to rapidly sense oxidative damage events in DNA from a
distance. In this model for SoxR activation, ROS and other
oxidants extract electrons from the DNA, leading to the
formation of DNA base radicals.111 Since guanine-rich sites have
the lowest oxidation potential within the genome, the resulting
holes will migrate via DNA CT to these sites.11 These guanine
radicals can then either react with solution molecules to form
stable damage products or continue to migrate to DNA-bound
proteins such as SoxR. Recall that the time scale for DNA CT
is nanoseconds or faster versus guanine reaction with water,
which is on the millisecond time scale. Activation of SoxR from
a distance in this fashion would allow these proteins to expand
the range of sensing beyond the physical space occupied by
the protein within the cell. Interestingly, the soxS promoter site
in E. coli contains two GGGG sites within 100 bp, and these
sites are conserved in many other enterics containing soxRS
regulons.
Figure 6. SoxR is able to exploit DNA as an antenna for sensing oxidative
stress conditions. Oxidative damage generates guanine radical intermediates,
which migrate over long distances in DNA. These species oxidize SoxR,
activating it to promote the transcription of soxS, inducing the oxidative
stress response in E. coli.
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This model is consistent with what is known about SoxR and
provides a rationale for rapid and sensitive activation of SoxR
as observed in ViVo. In keeping with this model, when guanine
radicals are selectively generated in DNA by photoexcited
[Rh(phi)2(bpy)]2+ tethered 80 bp (270 Å) from the SoxR binding
site, SoxR is activated and transcription is initiated, as deter-
mined by a reconstituted abortive transcription assay.13 In ViVo,
treatment of live E. coli with [Rh(phi)2(bpy)]2+ also induces
generation of the soxS transcript in response to illumination.
It is interesting that DNA-mediated oxidation of SoxR is so
facile, given the 20 Å separation between the cluster and the
DNA in the crystal structure of the oxidized species. It is
possible that the cluster is closer to the DNA in the reduced
state. Time-resolved transient absorption measurements154 and
computational study86 would both be useful in characterizing
CT across the SoxR-DNA interface.
4.2. Redox Signaling between BER Enzymes. While DNA
repair proteins are not typically viewed as participants in redox
signaling pathways, a class of base-excision repair (BER)
proteins, largely involved in repair of oxidative DNA damage,
binds an iron-sulfur cluster cofactor much like SoxR.172 It is
intriguing to consider whether this cofactor might confer upon
these DNA repair proteins additional redox regulatory and
functional properties.
MutY and Endonuclease III (EndoIII) are the most well
conserved enzymes in this class, with homologues present in a
wide variety of prokaryotic and eukaryotic organisms.172 In
BER, glycosylase enzymes, often present in low copy number,
must locate and recognize specific isolated damaged bases in
the genome and then excise these lesions.173 The first step of
this process, the initial search for lesions in the genome, is not
well understood. The presence of a redox-active iron-sulfur
cluster in these proteins may facilitate DNA-mediated redox
signaling as a particularly efficient damage detection mechanism
in this repair pathway.
MutY and EndoIII repair oxidatively damaged bases in the
genome.172,173 MutY removes adenines mispaired with 8-oxo-
guanine, while EndoIII excises a variety of oxidized pyrimidine
bases from DNA. Both enzymes are present within the cell in
extremely low copy number (<30/cell for MutY, 500/cell for
EndoIII).174 Despite their low abundance, MutY and EndoIII
are extremely effective in ViVo.175 Thus, how these enzymes
efficiently locate their substrates is a major question, as is the
function of the iron-sulfur cluster in these proteins.
A primary focus of study with these enzymes has been
exploring the mechanism, properties, and specificity of the
excision reaction both in Vitro and in ViVo.172,173 In addition,
X-ray crystal structures have been solved for E. coli MutY and
EndoIII as well as Geobacillus stereothermophilus MutY and
EndoIII cross-linked to substrate analogues in a short DNA
helix.176,177 Much is now understood regarding the structural
basis for substrate recognition in these proteins and the nature
of the enzymatic reaction. Both enzymes extrude their substrate
bases from the helix and bind them in a specific active site
pocket. Recognition is achieved on the basis of specific
interactions between protein sites and functional groups on the
lesion base. Scission of the glycosidic bond occurs by different
mechanisms in these enzymes, and these are also well
characterized.172,173 However, repair assays in E. coli cells
indicate that, in ViVo, the rate-limiting step in BER by MutY is
the initial detection of lesions rather than the base excision
reaction.178 These studies have revealed very little, however,
about the explicit role of the iron-sulfur cluster. DNA-bound
crystal structures reveal that the iron-sulfur cluster, though close
to the DNA backbone, is located far from the enzyme active
site and substrate recognition pocket and does not play a distinct
part in the excision reaction pathway.176,177 The cofactor is
required for nonspecific DNA binding and, thus, is essential
for overall activity.
Our laboratory has further investigated the role of the iron-
sulfur cluster in these proteins. MutY and EndoIII each contain
a [4Fe4S]2+ cluster ligated by four cysteine residues.176,177,179
In the absence of DNA, the iron-sulfur cluster is resistant to
oxidation and reduction; oxidation by solution-borne oxidants
results in loss of an iron atom to form [3Fe4S]+, while reduction
could only be accomplished using mediators with potentials
< -600 mV vs NHE.179 When examined at DNA-modified
electrode surfaces, MutY and EndoIII both display properties
markedly different from those seen in solution without
DNA.83,84,87 Robust and quasi-reversible signals are observed
with midpoint potentials (E1/2) between +50 and +100 mV vs
NHE. Observation of these electrochemical signals requires an
intact base-pair π-stack; the presence of an abasic site dramati-
cally diminishes the intensity of the electrochemical features.
Consistent with mediator experiments, electrochemical examina-
tion of EndoIII in the absence of DNA reveals features at both
higher (> +250 mV vs NHE) and lower potentials (< -400
mV).87 These peaks are far less reversible and distinct than those
present at DNA-modified surfaces. These features at high and low
potential are interpreted as the [4Fe4S]2+/3+ and [4Fe4S]2+/+ redox
couples, respectively. When bound to DNA, the [4Fe4S]2+/3+
couple shifts by -200 mV vs NHE, and redox activity is much
more robust. The DNA-associated forms of MutY and EndoIII
are both more easily oxidized than the free forms of the proteins
and more stable in the oxidized state. Furthermore, a distinct
requirement exists that iron-sulfur cluster oxidation and reduc-
tion be mediated by the DNA base-pair stack.
The -200 mV shift in redox potential upon DNA binding,
as with SoxR, is indicative of some form of energetic change
upon DNA binding by MutY and EndoIII, such as a change in
binding affinity or protein/DNA conformation. In these proteins,
unlike SoxR, it is known that the structure of the protein does
not change significantly upon DNA binding, nor do they induce
DNA distortion when nonspecifically bound.176,177,180,181 More-
over, for the repair proteins, DNA binding causes a negative
shift in redox potential, as one might expect upon binding to a
polyanion, versus the large positive shift in potential associated
with binding of SoxR to DNA. Thus, it is proposed that the
redox potential shift for the repair proteins translates to a
differential DNA-binding affinity for the oxidized and reduced
forms of the protein. The 200 mV shift estimated in electro-
chemical studies must correspond to an increased DNA-binding
affinity for the [4Fe4S]3+ form by >3 orders of magnitude.
A redox-active iron-sulfur cluster could allow MutY and
EndoIII to participate in redox reactions when bound to DNA.
The possibility that these reactions can occur via the DNA
π-stack may also permit these proteins to harness the exquisite
sensitivity of DNA-mediated CT reactions toward myriad
damaged and mismatched bases (including the substrates for
MutY and EndoIII).76,79 Our laboratory has described a model
illustrating how MutY and EndoIII might exploit DNA CT to
accomplish the first step of BER, which is the initial scan of
the genome for lesions (Figure 7).182 BER glycosylases initially
bind to DNA in a nonspecific fashion. In this first step, the
iron-sulfur clusters in the BER enzymes (e.g., MutY) are in
the [4Fe4S]2+ state. Upon binding to DNA, MutY is now more
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accessible to oxidation and, upon transformation to the
[4Fe4S]3+ state by myriad cellular oxidants, including guanine
radicals, now binds DNA much more tightly. If the surrounding
genome is free of damaged and mismatched bases, this MutY
molecule can be reduced, via the DNA π-stack, by distally
bound redox-active proteins of similar or greater reduction
potential. Instead, if a damaged site is present, oxidized repair
proteins will be less accessible for reduction via the DNA base-
pair stack and are more likely to remain tightly associated to
the DNA near the lesion site. This model provides not only a
rationale for the presence of a redox-active iron-sulfur cluster
in BER enzymes but also an explanation for fast and efficient
lesion detection by these enzymes in a genomic context. It has
been shown by simulation that allowing CT between individual
copies of MutY, for certain parameter ranges, can lead to protein
accumulation in the vicinity of a lesion.183,184
The first step of this damage detection pathway requires
oxidation of DNA-bound [4Fe4S] cluster repair proteins. As
proposed with SoxR, this could also occur via DNA CT through
formation of guanine radical cations that occur as a consequence
of oxidative DNA damage.86,111 This could be especially
significant for DNA repair, recruiting BER enzymes to local
genomic sites actively undergoing oxidative stress. We have
established that this chemistry can occur in Vitro using a Ru-
DNA assembly to generate guanine radicals via flash-quench
reactions.154 Guanine radicals are monitored directly via electron
paramagnetic resonance and transient absorption spectroscopies
and indirectly via trapping to form permanent oxidative damage
products visualized by gel electrophoresis. Flash-quench of these
assemblies in the presence of MutY shows quenching of the
guanine radical and formation of spectroscopic features typical
of oxidized iron-sulfur clusters. These results are consistent
with electron transfer from MutY to fill the hole present at
oxidized guanine sites and suggest that this activation pathway
is feasible within the cell.
The ultimate outcome of the proposed model is the clustering
of enzymes near damaged sites. This idea has been tested by
atomic force microscopy imaging of EndoIII bound to long
DNAs containing a site-specific mismatch (C:A) known to
attenuate DNA CT.182 In these experiments, a mixture of long
strands containing a single C:A mismatch and short matched
strands are incubated with EndoIII. Consistent with the CT
model, a greater proportion of proteins (1.6:1) are found bound
to the long strand containing the mismatch. When all strands
are matched, the long/short ratio is 0.9:1. Note that a C:A
mismatch is not a substrate for EndoIII, so the preference for
the mismatched strand does not reflect a direct affinity for the
mismatched site. The long/short ratio increases with increasing
concentrations of external oxidants such as hydrogen peroxide,
indicating a relationship between the accumulation of EndoIII
near the mismatch site and the oxidation state of the iron-sulfur
cluster. These experiments corroborate the prediction from the
model that enzymes using DNA CT for genome scanning will
redistribute onto regions near damaged sites.
Another important feature of the DNA CT damage detection
model is its ability to accommodate cooperative lesion detection
Figure 7. Redox-active base-excision repair (BER) enzymes can exploit DNA-mediated CT to rapidly assay regions of DNA for damage, such as oxidative
lesions. The presence of a lesion serves as a barrier for DNA CT, leading to accumulation of BER proteins near the lesion. Importantly, BER enzymes of
similar potential can assist each other in searching for damage. Here, the orange and blue proteins represent two different FeS cluster-containing proteins of
similar potential. In this model, guanine cation radical or another oxidative intermediate oxidizes a nearby BER FeS cluster to the tight-binding 3+ state (1).
Binding of reduced protein nearby (2) allows self-exchange (3), following which the first protein, now in the 2+ state, has decreased affinity for DNA and
can diffuse away (4). Steps 2-4 correspond to a net translation of 3+ protein on the DNA. This process is repeated when another reduced protein binds the
DNA on the other side (5,7), followed by self-exchange and dissociation of the newly reduced protein (6,8). The DNA is left empty of the 3+, and hence
strongly bound, protein (9). The directionality portrayed in (1-9) is illustrative, as the CT-mediated migration of 3+ protein is diffusive. When a lesion is
present, steps 10-14 mirror steps 1-5. Reduced protein distal to the lesion, however, is unable to reduce the oxidized protein through DNA-mediated CT
(15), increasing the residence of that particular 3+ protein near the lesion. CT-mediated migration of oxidized protein, as shown in the previous steps, can
oxidize reduced protein on the distal side of the lesion (16), and 3+ protein accumulated near the lesion can slide along the DNA (17) and repair the lesion
upon direct contact (18).
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by disparate DNA repair proteins. Electrons may transfer to any
redox-active DNA-binding protein and, in doing so, will transmit
information about the integrity of the surrounding DNA. This
may provide a further explanation for the low abundance yet
high in ViVo effectiveness of BER enzymes. We have tested
this putative cooperativity using established assays for MutY
activity in E. coli cells. If MutY and EndoIII, both present in
E. coli, search for lesions cooperatively via DNA CT, then
genetic inactivation of EndoIII should hinder damage detection
by MutY within the cell. EndoIII knockouts (nth-) indeed cause
a small decrease in MutY activity inside the cell. We have
examined the origin of this defect using site-directed mutagen-
esis. Introduction of an excision-deficient EndoIII mutant
(D138A) into the MutY reporter nth- strain restores activity,
while a mutant that is deficient in protein/DNA electron transfer
(Y82A EndoIII) remains inactive. These results support the idea
that MutY and EndoIII engage in a cooperative functional
relationship inside the cell that requires a fully redox-active
iron-sulfur cluster in EndoIII.
Many other models have been proposed for target location
by these DNA-binding proteins. All of these rely upon physical
interaction with genome sites to verify target or nontarget status.
These strategies may allow for efficient repair over a single cell
cycle for DNA repair enzymes in high copy number, but for
low copy number enzymes, such as MutY, they are insufficient
for effective substrate location. We have calculated the improve-
ment in genome scanning time for MutY in E. coli that would
be achieved using the DNA CT scanning model. In these
calculations, the interprotein CT distance and the proportion of
protein initially in the oxidized state are taken as variables, and
cooperative CT is assumed between MutY and EndoIII only.
A baseline genome scanning time in the absence of DNA CT
is determined for MutY, assuming only facilitated diffusion of
the protein with instantaneous interrogation of potential targets,
and is too long to account for effective repair within the cell
cycle. Allowing CT over 200-500 bp with 10-20% oxidized
protein, modeled with the diffusion of reduced protein to within
CT distance of a DNA-bound oxidized protein as the rate-
limiting step, gives genome scanning times of at least an order
of magnitude faster, comfortably within the cell cycle. Therefore,
DNA CT provides an explanation for efficient DNA repair by
MutY in ViVo, whereas other models fail in this respect.
Interestingly, these calculations indicate switch-like behavior
in the dependence of genome scanning time on the fraction of
oxidized protein at low levels of oxidation. This could allow
for an additional level of redox regulation in DNA repair by
MutY.
4.3. Activation of p53 by DNA-Mediated CT. The protein
p53 is a well-known example of a eukaryotic transcription factor
regulated by redox processes.185 p53 is also of high clinical
relevance, as it is found mutated in over 50% of cancers.186 As
a transcription factor, it activates many different genes involved
in apoptosis, cell cycle regulation, oxidative stress response,
repair, and autophagy.187 This transcriptional regulation occurs
in response to cellular stress that includes DNA damage,
oncogene activation, telomere elimination, and hypoxia. p53 can
respond to these events directly or in a protein-mediated fashion.
While in many cases the relationship between p53 and a
particular stress response is known, the chemical mechanisms
governing p53 activation are often not well understood.
Understanding these relationships is important since p53 plays
a key role in cancer prevention and aging.
The p53 gene product binds DNA as a tetramer and consists
of three individual domains (N-terminal transactivation, DNA
binding, and C-terminal tetramerization) as well as several
regions that are relatively unstructured.188 The DNA-binding
domain is where the majority of p53 mutations occur that are
associated with cancer. p53 binds DNA across two palindromic
half-sites of the form 5′-A/G A/G A/G C A/T A/T G C/T C/T
C/T-3′ separated by 0-13 bp. The DNA-binding domain forms
a  sandwich structure with distinct faces that interact with its
binding site over the major and minor grooves. This domain
also binds a zinc ion important for stability and DNA affinity.
Many contacts between protein side chains and DNA functional
groups are apparent that likely dictate sequence recognition and
specificity.
The protein p53 is one of many eukaryotic transcription
factors whose DNA affinity is modulated by thiol-disulfide
redox chemistry.185 In Vitro DNA binding by p53 requires a
reducing environment. Similarly, reagents that specifically
oxidize thiol groups prevent p53/DNA association. p53 contains
seven conserved cysteines in its DNA-binding domain.188 Three
of these are involved in binding zinc (C176, C238, C242), while
two are proposed to form a disulfide bond on the basis of
structural proximity (C275, C277). The remaining cysteines,
C135 and C141, are in close proximity to the DNA backbone.
While the redox modulation of p53 is established in Vitro, the
mechanism and functional consequences of this chemistry within
the cell are not well understood.
Redox modulation of p53 from a distance via DNA CT has
been examined using a pendant photooxidant assembly consist-
ing of a DNA sequence bearing a p53-specific promoter target
functionalized with a tethered anthraquinone (AQ).189 Irradiation
of AQ promotes DNA-mediated oxidation reactions. The ability
Figure 8. Delivery of radical holes induces dissociation of p53 from the promoter for GADD45, but not for p21. DNA-mediated CT serves as a mechanism
for efficient delivery of oxidation to p53, allowing a rapid redistribution from pro-repair to pro-apoptotic promoter sites.
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of this assembly to oxidize thiols from a distance has been
established using oligonucleotides containing thiol modifiers in
the DNA backbone.190 Photoinitiated oxidation of p53 bound
to a consensus promoter sequence yields dissociation of the
protein. Mass spectrometry confirms chemical changes in the
protein consistent with oxidation of conserved cysteines in
the DNA-binding domain. Experiments with p53 promoters for
genes involved in apoptosis (p21), negative feedback regulation
(mdm2), and DNA repair (GADD45) reveal sequence-specific
effects on DNA-mediated p53 oxidation. In particular, upon
photooxidation from a distance, p53 dissociates from the
GADD45 and mdm2 promoters. p53 is, however, not released
from the p21 promoter as a consequence of DNA-mediated
oxidation. These results indicate that p53 can also be oxidized
from a distance when bound to natural promoter sites and that
redox regulation may be sequence-specific (Figure 8). It is
interesting to consider the functional consequences of the latter
idea: DNA-mediated oxidation from a distance may signal
extreme stress such that, under these circumstances, p53 will
still induce apoptosis but not initiate DNA repair or engage in
negative feedback.
DNA-mediated oxidation of p53 has also been demonstrated
within the cell.189 Incubation of HeLa cells with a rhodium
photooxidant ([Rh(phi)2(bpy)]3+) yields formation of oxidized
p53, as determined by Western blotting. Similar results are also
observed upon cellular exposure to hydrogen peroxide. Thus,
p53 can be oxidized via DNA-mediated CT in an in ViVo setting
as well.
These experiments establish that thiol-disulfide redox chem-
istry is accessible via DNA-mediated charge transport. Further-
more, they describe a novel chemical pathway for redox
modulation of p53. Additional exploration of the sequence
specificity of DNA-mediated p53 oxidation may provide new
insight into the structural requirements for efficient protein-DNA
charge transport while illuminating new aspects of p53 regula-
tion of possible clinical importance.
5. Conclusions and Outlook
Signaling and sensing processes, as forms of communication,
are inherently coupled to location and distance. By offering a
medium for chemistry at a distance, the ability of DNA to
mediate CT provides a natural mechanism for redox sensing
and signaling in the genome. Here, we have illustrated how
charge migration in DNA may be employed to solve a series
of challenges to both prokaryotes and eukaryotes. Charge
migration through DNA allows oxidative stress to be funneled
either to a sensing protein, such as SoxR or p53, or to damage
hotspots that then affect protein recognition. Electron exchange
between proteins allows redox signaling to redistribute repair
proteins in the vicinity of lesions. Given the power of this
chemistry, how else might it be exploited by nature?
Table 1 lists a sampling of DNA-binding proteins, from a
variety of organisms, that contain moieties that are traditionally
redox-active under physiological conditions. We do not mean
to suggest that each of these proteins will be found to exploit
DNA-mediated CT in a physiological context. Indeed, redox
potentials for most of these have not yet been measured, and
even fewer measurements have been taken in the presence of
DNA, though such efforts are now ongoing in our laboratory.
Rather, we find it enticing that so many DNA-binding proteins
have been recently identified that have the potential to participate
in redox reactions. For many of these proteins, particularly for
those containing an iron-sulfur cluster, the redox-active moiety
serves no apparent catalytic role yet is highly conserved. The
examples in humans are particularly intriguing. FancJ is required
for repair of double-strand breaks and of interstrand cross-links,
while XPD is required for other forms of nucleotide excision
repair. The p58 component of human DNA primase is required
for replication and some repair processes. Increasingly, proteins
with iron-sulfur clusters are being identified as essential to early
steps in each of the various types of DNA processing. Eukaryotic
DNA processing typically involves macromolecular assemblies
containing a diversity of protein components, many of which
are now unknown. Perhaps a common component of these
assemblies is generally available for redox sensing. Certainly
as new components of these macromolecular machines are
revealed and characterized, the list of proteins involved that
contain iron-sulfur clusters will continue to grow. As new
biological roles for the iron-sulfur clusters in Table 1 are
determined, new insight will be gained into how redox reactions
can be chemically exploited to enable the functions of DNA-
binding proteins.
But an iron-sulfur cluster is not essential for this signaling.
It has been well established that many transcription factors are
regulated by the redox state of cysteine. We have demonstrated
that one of the most significant of these, p53, can be regulated
in a site-selective manner by DNA-mediated CT. Detailed
chemical mechanisms of reduction and oxidation have not been
worked out for the majority of these factors, and it is unknown
how many are sufficiently well-coupled to the DNA π stack to
be regulated by redox reaction through DNA. Using the entire
genome as an antenna for oxidative stress is an attractive
alternative to relying on diffusion of ROS to the sensing protein.
We have demonstrated a few ways in which a chemical
reaction, DNA-mediated charge transport, is exploited for
biological roles. The chemistry of DNA-mediated CT to and
between proteins has only begun to be characterized. As new
understanding of this process emerges and new participants are
identified, undoubtedly, critical chemical mechanisms inside
living cells will be revealed.
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